Literature DB >> 11192496

Increases in the mutation frequency at which fusidic acid-resistant Staphylococcus aureus arise with salicylate.

Christopher T D Price1, John E Gustafson1.   

Abstract

Salicylate was shown to increase the frequency at which a fusidic acid-susceptible strain of Staphylococcus aureus underwent mutation to become fusidic acid-resistant. These fusidic acid-resistant mutants had alterations in spectinomycin and kanamycin resistance levels indicative of mutations in fusA, the gene that encodes elongation factor-G, the target of fusidic acid.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11192496     DOI： 10.1099/0022-1317-50-1-104

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


  8 in total

1.  Fusidic acid monotherapy.

Authors:  V Vassiliou; A K Demetriades; G Scott
Journal:  J R Soc Med       Date:  2002-05       Impact factor: 5.344

2.  Contributions of sigB and sarA to distinct multiple antimicrobial resistance mechanisms of Staphylococcus aureus.

Authors:  James T Riordan; Jessica O O'Leary; John E Gustafson
Journal:  Int J Antimicrob Agents       Date:  2006-06-14       Impact factor: 5.283

Review 3.  Antimicrobial Effects of Antipyretics.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

4.  Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus.

Authors:  Silke Besier; Albrecht Ludwig; Volker Brade; Thomas A Wichelhaus
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Response of Staphylococcus aureus to salicylate challenge.

Authors:  James T Riordan; Arunachalam Muthaiyan; Wayne Van Voorhies; Christopher T Price; James E Graham; Brian J Wilkinson; John E Gustafson
Journal:  J Bacteriol       Date:  2006-10-20       Impact factor: 3.490

6.  Salicylic acid diminishes Staphylococcus aureus capsular polysaccharide type 5 expression.

Authors:  Lucía P Alvarez; María S Barbagelata; Mariana Gordiola; Ambrose L Cheung; Daniel O Sordelli; Fernanda R Buzzola
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

7.  The fusidic acid stimulon of Staphylococcus aureus.

Authors:  Alejandro Delgado; Shahrear Zaman; Arunachalam Muthaiyan; Vijayaraj Nagarajan; Mohamed O Elasri; Brian J Wilkinson; John E Gustafson
Journal:  J Antimicrob Chemother       Date:  2008-09-10       Impact factor: 5.790

8.  Alterations in the transcriptome and antibiotic susceptibility of Staphylococcus aureus grown in the presence of diclofenac.

Authors:  James T Riordan; JoAnne M Dupre; Stephanie A Cantore-Matyi; Atul Kumar-Singh; Yang Song; Shahrear Zaman; Sonia Horan; Nada S Helal; Vijayaraj Nagarajan; Mohamed O Elasri; Brian J Wilkinson; John E Gustafson
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-07-21       Impact factor: 3.944
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.